- en: <!--yml
  prefs: []
  type: TYPE_NORMAL
- en: 'category: 未分类'
  prefs: []
  type: TYPE_NORMAL
- en: 'date: 2024-05-18 00:49:32'
  prefs: []
  type: TYPE_NORMAL
- en: -->
  prefs: []
  type: TYPE_NORMAL
- en: 'Humble Student of the Markets: Some deep value stocks'
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: 来源：[https://humblestudentofthemarkets.blogspot.com/2009/07/some-deep-value-stocks.html#0001-01-01](https://humblestudentofthemarkets.blogspot.com/2009/07/some-deep-value-stocks.html#0001-01-01)
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: Given the
  prefs: []
  type: TYPE_NORMAL
- en: '[medium term risks](http://humblestudentofthemarkets.blogspot.com/2009/07/sanity-check-for-bulls_24.html)'
  prefs: []
  type: TYPE_NORMAL
- en: for the stock market, I thought that I would highlight a few deep value stocks
    that may provide some downside protection from the cushion of fundamental value.
  prefs: []
  type: TYPE_NORMAL
- en: '**Stocks trading below net cash**'
  prefs: []
  type: TYPE_NORMAL
- en: 'I screened my database of US listed stocks for companies that trade below net
    cash (cash less all debt) and are showing positive earnings. The positive earnings
    test is a second check for the viability of the enterprise, as a deteriorating
    income statement could easily wipe out any value shown on a balance sheet. Not
    surprisingly, the pickings were rather slim given the market''s extended nature:'
  prefs: []
  type: TYPE_NORMAL
- en: Health Net Inc (HNT) and Pain Therapeutics Inc (PTIE)
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: '**Stocks trading below net net working capital**'
  prefs: []
  type: TYPE_NORMAL
- en: 'This is a classic Ben Graham screen. I looked for stocks trading below net-net
    working capital (current assets – all liabilities) and are showing positive earnings:'
  prefs: []
  type: TYPE_NORMAL
- en: Cynosure Inc (CYNO) and Volt Information Sciences Inc (VOL)
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: I would not blindly buy these names but take this small list as a starting point
    for further analysis. I know nothing about the outlook or fundamentals of these
    companies. In particular, I would be cautious about Pain Therapeutics as it had
    shown a spate of insider selling.
  prefs: []
  type: TYPE_NORMAL
